| 三精制药 （600829） 重要财务指标 |
| 2007-9-30 | 2007-6-30 | 2007-3-31 | | 每股收益摊薄 | 0.455 | 0.261 | 0.132 | | 每股收益加权平均 | 0.455 | 0.261 | 0.130 | 每股收益摊薄
（扣除非经常性损益后） | | | | 每股收益加权平均
（扣除非经常性损益后） | 0.379 | | | | 每股净资产 | 3.010 | 2.820 | 2.680 | | 每股净资产（调整后） | | | | | 每股经营活动产生的现金流量净额 | 0.640 | -0.420 | -0.120 | | 净资产收益率摊薄（%） | 15.09 | 9.27 | 4.41 | | 净资产收益率加权（%） | | | | | 主营业务收入 | 1,531,657,885.40 | 988,053,975.90 | 503,836,138.53 | | 主营业务利润 | 749,371,212.93 | | | | 营业利润 | 198,544,264.65 | 119,559,244.28 | 60,627,786.13 | | 投资收益 | 17,842,234.00 | 8,607,556.25 | 4,175,165.78 | | 营业外收支净额 | | | | | 利润总额 | 211,949,632.31 | 121,471,223.06 | 60,550,345.45 | | 净利润 | 175,716,258.57 | 100,991,014.31 | 51,184,016.80 | | 净利润（扣除非经常性损益后） | | 91,180,095.22 | | | 经营活动产生的现金流量净额 | 248,423,343.01 | -163,014,571.48 | -48,134,497.80 | | 现金及现金等价物净增加额 | 176,375,830.51 | -204,365,219.63 | -78,964,593.50 | | 流动资产 | 1,794,926,447.48 | 1,289,170,831.02 | 1,449,858,231.37 | | 流动负债 | 1,244,461,314.98 | 814,596,218.79 | 1,029,877,367.17 | | 总资产 | 2,670,181,329.90 | 2,162,494,735.88 | 2,313,627,933.78 | | 股东权益不含少数股东权益 | 1,164,104,177.54 | 1,089,542,133.29 | 1,036,434,053.66 |
|
